Stronger warnings about using the stimulant Cylert (pemoline) for ADHD

February 1997

    You'll see stronger warnings about using the stimulant Cylert (pemoline) for ADHD...because of the risk of hepatotoxicity.

    A new boxed warning in the package insert describes reports of acute liver failure...some resulting in death or a liver transplant.

    Now some physicians aren't refilling Cylert scripts until they check liver function tests. But this might not be good enough.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote